Physician profile
Peter Trinca
NPI 1801830369
$5,088.61
in general payments reported to CMS, 2019-2025
29 companies · $272 in 2025
The $272 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,262 · 2020: $314 · 2021: $271 · 2022: $314 · 2023: $386 · 2024: $270 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $2,787.68 | 2019-2020 | |
| Astellas Pharma US INC | $489.13 | 2019-2023 | Myrbetriq |
| Teleflex LLC | $482.60 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $337.96 | 2019-2025 | Advance Xp, Ams 700, Lithovue |
| Urogen Pharma, INC. | $125.80 | 2024-2025 | |
| Abbvie INC. | $121.39 | 2019-2025 | |
| Olympus America INC. | $96.55 | 2019-2025 | Itind System |
| Janssen Biotech, INC. | $89.66 | 2019-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $57.51 | 2023-2024 | Orgovyx |
| Laborie Medical Technologies Corp. | $53.82 | 2023 | |
| Coloplast Corp | $53.72 | 2020-2023 | Porges Coloplast |
| Myriad Genetic Laboratories, INC. | $42.04 | 2023 | Prolaris |
| Tolmar, INC. | $40.52 | 2023-2024 | |
| Pfizer INC. | $40.39 | 2019-2024 | |
| Myovant Sciences INC. | $31.62 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $30.78 | 2023 | Perclot |
| Ferring Pharmaceuticals INC. | $27.89 | 2025 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $23.57 | 2024 | |
| Procept Biorobotics Corporation | $23.15 | 2022 | |
| Axonics, INC. | $22.54 | 2023 | Axonics |
| Blue Earth Diagnostics | $19.02 | 2019 | |
| Karl Storz Endoscopy-America | $17.99 | 2024 | |
| Photocure INC | $14.46 | 2023 | Cysview |
| Cook Medical LLC | $13.68 | 2020 | |
| Amgen INC. | $13.43 | 2019 | |
| Davol INC. | $13.15 | 2023 | |
| Urovant Sciences INC | $11.71 | 2022 | |
| Clarus Therapeutics INC. | $5.75 | 2021 | |
| Travere Therapeutics, INC. | $1.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Trinca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.